Dian Xiao

1.0k total citations · 1 hit paper
26 papers, 706 citations indexed

About

Dian Xiao is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Dian Xiao has authored 26 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Dian Xiao's work include Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (8 papers) and Neuroscience of respiration and sleep (4 papers). Dian Xiao is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (8 papers) and Neuroscience of respiration and sleep (4 papers). Dian Xiao collaborates with scholars based in China and Czechia. Dian Xiao's co-authors include Lianqi Liu, Xinbo Zhou, Shiyong Fan, Yanming Wang, Fei Xie, Zheng Su, Song Li, Xinbo Zhou, Wu Zhong and Fei Xie and has published in prestigious journals such as Angewandte Chemie International Edition, International Journal of Molecular Sciences and Cell Death and Differentiation.

In The Last Decade

Dian Xiao

26 papers receiving 688 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody–drug conjugates: Recent advances in linker chemistry

2021 221 citations Zheng Su, Dian Xiao et al. Acta Pharmaceutica Sinica B profile →

Peers

Dian Xiao

ONCOL

MB

RNMI

ID

OC

Mohammad Zahid Kamran India

Markella Konstantinidou Netherlands

Wenfang Xu China

Luca Gambini United States

Viral Kansara United States

Daniel Kwon Canada

Fei You United States

Xiujun Liu China

Shurong Hou United States

Linghao Kong China

Mohammad Zahid Kamran India

Dian Xiao

227 ×0.8

ONCOL

313 ×1.2

MB

80 ×0.4

RNMI

59 ×0.8

ID

46 ×0.6

OC

Citations per year, relative to Dian Xiao Dian Xiao (= 1×) peers Mohammad Zahid Kamran

Countries citing papers authored by Dian Xiao

Since Specialization

Citations

This map shows the geographic impact of Dian Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dian Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dian Xiao more than expected).

Fields of papers citing papers by Dian Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dian Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dian Xiao. The network helps show where Dian Xiao may publish in the future.

Co-authorship network of co-authors of Dian Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Dian Xiao. A scholar is included among the top collaborators of Dian Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dian Xiao. Dian Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Xiao, Dian, Fei Xie, Jianfeng Wang, et al.. (2025). Polyvalent folate receptor-targeting chimeras for degradation of membrane proteins. Nature Chemical Biology. 21(11). 1731–1741. 5 indexed citations

2.

Long, Yu, Fei Xie, Lianqi Liu, et al.. (2025). Novel Quaternary Ammonium Salt‐Linked STING Agonist Antibody‐Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off‐Target Toxicity. Advanced Science. 12(31). e02270–e02270. 2 indexed citations

3.

Xiao, Dian, Lianqi Liu, Fei Xie, et al.. (2024). Azobenzene‐Based Linker Strategy for Selective Activation of Antibody–Drug Conjugates. Angewandte Chemie. 136(16). 3 indexed citations

4.

Xiao, Dian, Lianqi Liu, Fei Xie, et al.. (2024). Azobenzene‐Based Linker Strategy for Selective Activation of Antibody–Drug Conjugates. Angewandte Chemie International Edition. 63(16). e202310318–e202310318. 21 indexed citations

5.

Yin, Mingxiao, Jingwen Dong, Cuicui Sun, et al.. (2023). Raddeanin A Enhances Mitochondrial DNA‐cGAS/STING Axis‐Mediated Antitumor Immunity by Targeting Transactive Responsive DNA‐Binding Protein 43. Advanced Science. 10(13). e2206737–e2206737. 33 indexed citations

6.

Liu, Xiaojia, Na Zhang, Jingwen Dong, et al.. (2023). USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1. Cell Death and Differentiation. 30(10). 2249–2264. 34 indexed citations

7.

Su, Zheng, Fei Xie, Xin Xu, et al.. (2022). Development of a nitroreductase-dependent theranostic payload for antibody-drug conjugate. Bioorganic Chemistry. 129. 106190–106190. 4 indexed citations

8.

Liu, Lianqi, et al.. (2022). Design, synthesis and biological activity evaluation of a series of bardoxolone methyl prodrugs. Bioorganic Chemistry. 124. 105831–105831. 8 indexed citations

9.

Su, Zheng, Dian Xiao, Fei Xie, et al.. (2021). Antibody–drug conjugates: Recent advances in linker chemistry. Acta Pharmaceutica Sinica B. 11(12). 3889–3907. 221 indexed citations breakdown →

10.

Xiao, Dian, Lei Zhao, Fei Xie, et al.. (2021). A bifunctional molecule-based strategy for the development of theranostic antibody-drug conjugate. Theranostics. 11(6). 2550–2563. 19 indexed citations

11.

Xiao, Dian, Longlong Luo, Zhihong Wang, et al.. (2021). Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation. Bioorganic Chemistry. 116. 105366–105366. 22 indexed citations

12.

Wang, Yanming, Lianqi Liu, Shiyong Fan, et al.. (2020). Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety. Cancers. 12(3). 744–744. 26 indexed citations

13.

Xue, Fei, Xinbo Zhou, Xiaohan Zhou, et al.. (2020). Improvement of the C-glycosylation Step for the Synthesis of Remdesivir. Organic Process Research & Development. 24(9). 1772–1777. 27 indexed citations

14.

Fan, Shiyong, et al.. (2020). Research Progress on Repositioning Drugs and Specific Therapeutic Drugs for SARS-CoV-2. Future Medicinal Chemistry. 12(17). 1565–1578. 22 indexed citations

15.

Cao, Ruiyuan, Hengrui Hu, Yufeng Li, et al.. (2020). Anti-SARS-CoV-2 Potential of Artemisinins In Vitro. ACS Infectious Diseases. 6(9). 2524–2531. 117 indexed citations

16.

Xiao, Dian, Fei Xie, Wei Li, et al.. (2020). Novel antibody-drug conjugate with UV-controlled cleavage mechanism for cytotoxin release. Bioorganic Chemistry. 111. 104475–104475. 20 indexed citations

17.

Wang, Yanming, Shiyong Fan, Dian Xiao, et al.. (2019). Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy. Cancers. 11(7). 957–957. 33 indexed citations

18.

Dai, Wei, et al.. (2019). The Impact and Mechanism of a Novel Allosteric AMPA Receptor Modulator LCX001 on Protection Against Respiratory Depression in Rodents. Frontiers in Pharmacology. 10. 105–105. 16 indexed citations

19.

Dai, Wei, et al.. (2017). A brain-targeted ampakine compound protects against opioid-induced respiratory depression. European Journal of Pharmacology. 809. 122–129. 17 indexed citations

20.

Xiao, Dian, et al.. (2016). Design, Synthesis and Biological Evaluation of Brain-Targeted Thiamine Disulfide Prodrugs of Ampakine Compound LCX001. Molecules. 21(4). 488–488. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact